Postprandial Glucose Levels Are Better Associated with the Risk Factors for Diabetes Compared to Fasting Glucose and Glycosylated Hemoglobin (HbA1c) Levels in Elderly Prediabetics: Beneficial Effects of Polyherbal Supplements—A Randomized, Double-Blind, Placebo Controlled Trial

Table 1

Basic characteristics of the study participants who completed the 12-week study (N=88).

	GlucoVita	Placebo	Total	chi-square or t value	P
	(N=43)	(N=45)
Gender
Male	17(39.5%)	15(33.3%)	32 (36.4%)	0.365	0.545
Female	26(60.5%)	30(66.7%)	56 (63.6%)
Age, years (mean±s.d.)
Male	63.2±7.53	67.71±7.27	65.31±7.64
Female	63.81±8.60	60.69±6.82	62.14±7.79
Total	63.57±8.11	63.03±7.66	63.29±7.84	0.320	0.750
Age, years (range)
Male	53.05-78.18	52.38-78.24	52.38-78.24
Female	52.29-78.52	49.38-78.56	49.38-78.56
Status
IFG	16(37.2%)	16(35.6%)	32(36.4%)	1.813	0.404
I2hPG	16(37.2%)	12(26.7%)	28(31.8%)
IFG&I2hPG	11(25.6%)	17(37.8%)	28(31.8%)
BMI
Normal	13(30.2%)	12(26.7%)	25(28.4%)	0.137	0.934
Overweight	20(46.5%)	22(48.9%)	42(47.7%)
Obese	10(23.3%)	11(24.4%)	21(23.9%)
BMI (kg/m^2) (mean±s.d.)
	25.64±3.42	25.63±3.30	25.64±3.34	0.009	0.993
Weight (kg) (mean±s.d.)
	64.23±9.89	65.63±11.28	64.95±10.59	-0.618	0.538
Hyperlipidemia
No	26(60.5%)	29(64.4%)	55(62.5%)	0.149	0.700
Yes	17(39.5%)	16(35.6%)	33(37.5%)
Hypertension
No	14(32.6%)	13(28.9%)	27(30.7%)	0.139	0.709
Yes	29(67.4%)	32(71.1%)	61(69.3%)
Duration of disease, years (mean±s.d.)
	2.87±3.89	2.34±1.42	2.60±2.90	0.855	0.395
Symptoms
No	23(53.49%)	24(53.33%)	47(53.4%)	0.0002	0.988
yes	20(46.51%)	21(46.67%)	41(46.6%)

are numbers of individuals (%) unless otherwise indicated.